February 29, 2012 -- WHO: David Gollaher, Ph.D., CHI President and CEO, and Mark Mercola, Ph.D., Professor and Director, Muscle Development and Regeneration Program, Sanford-Burnham Medical Research Institute
WHAT: In CHI’s most recent podcast series, Gollaher and Mercola discuss cardiovascular disease research; including regenerative techniques Mercola is testing in his laboratories at Sanford-Burnham Medical Research Institute to restore damaged heart tissue. They also discuss the funding environment for academic research and the challenges behind engaging student interest in science, math and engineering.
In California, cardiovascular disease is the leading cause of death. The burden of cardiovascular disease is experienced across the California population, although some groups experience the burden disproportionately. Of further concern, given the changing demographics in California, is that the risk of death from heart disease, stroke, and heart failure increases with age.
WHEN: Wednesday, Feb. 29
HOW: To download the podcast, visit www.chi.org and click on “Multimedia” or visit iTunes. To subscribe to the series click on the RSS Feed.
ABOUT CHI: CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.